Assessment of Kidney Function in Survivors Following Fontan Palliation
- 22 April 2016
- journal article
- Published by Computers, Materials and Continua (Tech Science Press) in Congenital Heart Disease
- Vol. 11 (6), 630-636
- https://doi.org/10.1111/chd.12358
Abstract
The Fontan operation is a palliative procedure for congenital single ventricle heart disease. Long-term kidney function in this cohort is not well-known. Our aim was to evaluate renal function in long-term survivors post-Fontan palliation, and we hypothesize that this cohort will have a higher prevalence of chronic kidney disease (CKD) compared to controls.We performed a retrospective cohort study of 68 subjects evaluated through the Single Ventricle Survivorship Program at the Children's Hospital of Philadelphia between July 2010 and December 2014 compared to 70 healthy children similar in age and sex. Primary outcome was CKD, defined as estimated glomerular filtration rate (eGFR) <90 mL/min/1.73 m(2) using creatinine and cystatin C-based estimating equations. Secondary outcomes included proteinuria and elevated intact parathyroid hormone.The Fontan cohort included 68 subjects with median age 13 years (IQR 9.0, 17.3) who were median 11.1 years (IQR 6.5, 15.7) post-Fontan palliation. This cohort was compared to 70 healthy individuals (median age 15.5 years (IQR 12.5, 18.3). Although median eGFRs were comparable: 102.6 vs. 101.9 mL/min/1.73 m(2) (P = .89) in Fontan vs. healthy subjects <18 years of age (Full CKiD equation), and 128.5 vs. 129.7 mL/min/1.73 m(2) (P = .56) in Fontan vs. healthy subjects ≥18 years of age (CKD-EPI creatinine and cystatin formula); 10% of Fontan subjects had an eGFR<90 mL/min/1.73 m(2) . Median intact parathyroid hormone level was higher at 59.4 pg/mL (IQR 43.0, 83.1) in the Fontan group compared to 23.4 pg/mL (IQR 16.7, 30.0) in controls (P ≤ .001). Proteinuria was present in 10% of the Fontan group compared to 4.7% in controls (P = .27).Ten percent of long-term survivors post-Fontan palliation had eGFR <90 ml/min/1.73 m(2) , and higher median parathyroid hormone levels compared to controls. Taken together, these measures may indicate early kidney disease. Future studies will focus on longitudinal assessment of kidney function and evaluation of risk factors for CKD post-Fontan palliation.Keywords
Funding Information
- Single Ventricle Survivorship Program
This publication has 27 references indexed in Scilit:
- Deficits in bone density and structure in children and young adults following Fontan palliationBone, 2015
- Usefulness of Insulinlike Growth Factor 1 as a Marker of Heart Failure in Children and Young Adults After the Fontan Palliation ProcedureThe American Journal of Cardiology, 2015
- Redefining Expectations of Long-Term Survival After the Fontan ProcedureCirculation, 2014
- Cyanotic Nephropathy-A Morphometric AnalysisCongenital Heart Disease, 2013
- The failing Fontan: etiology, diagnosis and managementExpert Review of Cardiovascular Therapy, 2011
- Four decades of Fontan palliationNature Reviews Cardiology, 2010
- The Fontan circulation: who controls cardiac output?Interactive CardioVascular and Thoracic Surgery, 2010
- Forty Years of The Fontan Operation: A Failed StrategySeminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual, 2010
- Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart DiseaseCirculation, 2008
- Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan SurgeryCirculation, 2008